Company page

Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc. (ticker: KYTX) is a public company based in the United States, focused on developing innovative therapies. With a market capitalization of approximately $450.5 million, Kyverna is positioned within the biotechnology sector. The company aims to advance its research and development efforts to address unmet medical needs.